These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7729916)

  • 21. Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humans.
    Alfa MJ; Olson N; Degagne P; Slaney L; Plummer F; Namaara W; Ronald AR
    Sex Transm Dis; 1992; 19(6):309-14. PubMed ID: 1492255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzyme immunoassays (EIAs) for the detection of anti-Haemophilus ducreyi serum IgA, IgG, and IgM antibodies.
    Roggen EL; Hoofd G; Van Dyck E; Piot P
    Sex Transm Dis; 1994; 21(1):36-42. PubMed ID: 8140487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of, antibody response to, and immunity induced by Haemophilus ducreyi hemolysin.
    Dutro SM; Wood GE; Totten PA
    Infect Immun; 1999 Jul; 67(7):3317-28. PubMed ID: 10377108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron and virulence of Haemophilus ducreyi in a primate model.
    Sturm AW
    Sex Transm Dis; 1997 Feb; 24(2):64-8. PubMed ID: 9111750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examination of early interactions between Haemophilus ducreyi and host cells by using cocultured HaCaT keratinocytes and foreskin fibroblasts.
    Zaretzky FR; Kawula TH
    Infect Immun; 1999 Oct; 67(10):5352-60. PubMed ID: 10496916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunization using HgbA in a recombinant chancroid vaccine delivered by attenuated Salmonella typhimurium SL3261 in the temperature-dependent rabbit model.
    Breau C; Cameron DW; Desjardins M; Lee BC
    J Immunol Methods; 2012 Jan; 375(1-2):232-42. PubMed ID: 22100216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies reactive with all strains of Haemophilus ducreyi.
    Hansen EJ; Loftus TA
    Infect Immun; 1984 Apr; 44(1):196-8. PubMed ID: 6200440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of pili expressed by Haemophilus ducreyi.
    Spinola SM; Castellazzo A; Shero M; Apicella MA
    Microb Pathog; 1990 Dec; 9(6):417-26. PubMed ID: 1982953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.
    Spinola SM; Li W; Fortney KR; Janowicz DM; Zwickl B; Katz BP; Munson RS
    Infect Immun; 2012 Feb; 80(2):679-87. PubMed ID: 22144477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Swine model of Haemophilus ducreyi infection.
    Hobbs MM; San Mateo LR; Orndorff PE; Almond G; Kawula TH
    Infect Immun; 1995 Aug; 63(8):3094-100. PubMed ID: 7622236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.
    Kesavalu L; Ebersole JL; Machen RL; Holt SC
    Infect Immun; 1992 Apr; 60(4):1455-64. PubMed ID: 1312516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.
    Ahmed HJ; Frisk A; Månsson JE; Schweda EK; Lagergård T
    Infect Immun; 1997 Aug; 65(8):3151-8. PubMed ID: 9234768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.
    Borrelli S; Roggen EL; Hendriksen D; Jonasson J; Ahmed HJ; Piot P; Jansson PE; Lindberg AA
    Infect Immun; 1995 Jul; 63(7):2665-73. PubMed ID: 7790083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.
    Hiltke TJ; Bauer ME; Klesney-Tait J; Hansen EJ; Munson RS; Spinola SM
    Microb Pathog; 1999 Feb; 26(2):93-102. PubMed ID: 10090856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A primate model for chancroid.
    Totten PA; Morton WR; Knitter GH; Clark AM; Kiviat NB; Stamm WE
    J Infect Dis; 1994 Jun; 169(6):1284-90. PubMed ID: 8195605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection.
    Al-Tawfiq JA; Bauer ME; Fortney KR; Katz BP; Hood AF; Ketterer M; Apicella MA; Spinola SM
    J Infect Dis; 2000 Mar; 181(3):1176-9. PubMed ID: 10720550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi.
    Abeck D; Freinkel AL; Korting HC; Szeimis RM; Ballard RC
    Int J STD AIDS; 1997 Sep; 8(9):585-8. PubMed ID: 9292349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi.
    Tuffrey M; Alexander F; Ballard RC; Taylor-Robinson D
    J Exp Pathol (Oxford); 1990 Apr; 71(2):233-44. PubMed ID: 2331407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of an enzyme immunoassay for human antibody to Haemophilus ducreyi.
    Desjardins M; Thompson CE; Filion LG; Ndinya-Achola JO; Plummer FA; Ronald AR; Piot P; Cameron DW
    J Clin Microbiol; 1992 Aug; 30(8):2019-24. PubMed ID: 1500508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of enzyme immunoassays for antibodies to Haemophilus ducreyi in a community outbreak of chancroid in the United States.
    Chen CY; Mertz KJ; Spinola SM; Morse SA
    J Infect Dis; 1997 Jun; 175(6):1390-5. PubMed ID: 9180178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.